{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "Corline Biomedical AB", "longName": "Corline Biomedical AB", "messageBoardId": "finmb_290512131", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketChangePercent": 0.56338245, "regularMarketPrice": 17.85, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.10075567, "fiftyTwoWeekLow": 7.6, "fiftyTwoWeekHigh": 19.85, "earningsTimestamp": 1682679540, "earningsTimestampStart": 1682679540, "earningsTimestampEnd": 1682679540, "trailingAnnualDividendRate": 0.0, "trailingPE": 89.25, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.2, "epsForward": 5.4, "epsCurrentYear": 0.05, "priceEpsCurrentYear": 357.0, "sharesOutstanding": 21490800, "bookValue": 4.401, "fiftyDayAverage": 10.698, "fiftyDayAverageChange": 7.1520004, "fiftyDayAverageChangePercent": 0.66853625, "twoHundredDayAverage": 9.73385, "twoHundredDayAverageChange": 8.116151, "twoHundredDayAverageChangePercent": 0.8338069, "marketCap": 383610784, "forwardPE": 3.3055556, "priceToBook": 4.0558963, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.10000038, "regularMarketTime": 1684142636, "regularMarketDayHigh": 17.85, "regularMarketDayRange": "17.0 - 17.85", "regularMarketDayLow": 17.0, "regularMarketVolume": 18351, "regularMarketPreviousClose": 17.75, "bid": 17.2, "ask": 17.85, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 17.8, "averageDailyVolume3Month": 22195, "averageDailyVolume10Day": 65930, "fiftyTwoWeekLowChange": 10.25, "fiftyTwoWeekLowChangePercent": 1.3486842, "fiftyTwoWeekRange": "7.6 - 19.85", "fiftyTwoWeekHighChange": -2.0, "firstTradeDateMilliseconds": 1433314800000, "symbol": "CLBIO.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Lefflersgatan 5", "city": "Uppsala", "zip": "754 50", "country": "Sweden", "phone": "46 18 71 30 90", "website": "https://www.corline.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent use for the treatment of acute or threatened vessel closure during coronary angioplasty. The company was incorporated in 1991 and is based in Uppsala, Sweden.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henrik  Nittmar Ph.D.", "age": 56, "title": "Chief Exec. Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Gunnar  Tufveson", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}